Dezhan Healthcare Co Ltd

Chart & Performance

D1W1MN

P/E

—

P/S

17.07

EPS

—

Div Yield, %

—

Shrs. gr., 5y

-0.96%

Rev. gr., 5y

-16.25%

Revenues

397m

-14.94%

Net income

-345m

L+1,592.15%

CFO

Dividend

Jun 01, 20210.21 CNY/sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Dezhan Healthcare Company Limited operates primarily within the Chinese market, specializing in the research, development, manufacturing, and distribution of pharmaceutical products, with a particular focus on cardiovascular and cerebrovascular medications. The company's product range also extends to include oncology drugs, a variety of health and wellness products, functional beverages, and ecological water. Established in 1998, the firm maintains its headquarters in Urumqi, China.

URL

http://www.dezhanhealthcare.com/

IPO date

May 19, 1998

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title CNY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title CNY in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT